Publication:
Determination of the Plasma Levels of Growth Arrest Specific 6 in Colon Cancer Patients

Simple item page
dc.contributor.authorBİNGÖL ÖZAKPINAR, ÖZLEM
dc.contributor.authorsTezcan S., İzzettin F., Özakpınar Ö., Attaallah V., Yumuk P., Uras F.
dc.date.accessioned2023-07-10T11:37:12Z
dc.date.available2023-07-10T11:37:12Z
dc.date.issued2023-06-01
dc.description.abstractObjective: Growth arrest-specific 6 (GAS 6) has a role in cell proliferation and was detected in different cancer types. The aim of this study was to evaluate the plasma GAS 6 levels in colon cancer patients. Methods: This was a prospective study and conducted in a research and training hospital in Turkey. Thirty-three healthy volunteers were enrolled in the control group, thirty-three colon cancer patients who were diagnosed with colon cancer for the first time. Sociodemographic characteristics of participants were recorded. Blood samples of the control group were taken once a time. Patients’ blood samples were taken before and one month after surgery. Results: There were no statistically significant differences between the sociodemographic characteristics of the two groups. The mean plasma GAS 6 levels in control were significantly higher than that of colon cancer patients (p<.0001). There is a statistically significant increase in GAS 6 values after surgery (p<.0001). Conclusion: It was observed that plasma GAS 6 levels of the patients were lower than the control group and were elevated after surgery. We think that our study will contribute to the literature in addition to studies showing that GAS 6 levels may be associated with survival and prognosis in different cancer types. Keywords: Colon cancer, growth arrest-specific 6, patient, plasma levels
dc.identifier.citationTezcan S., İzzettin F., Özakpınar Ö., Attaallah V., Yumuk P., Uras F., "Determination of the Plasma Levels of Growth Arrest Specific 6 in Colon Cancer Patients", CLINICAL AND EXPERIMENTAL HEALTH SCIENCES, cilt.13, sa.13, ss.400-403, 2023
dc.identifier.doi10.33808/clinexphealthsci.1126447
dc.identifier.endpage403
dc.identifier.issn2459-1459
dc.identifier.issue13
dc.identifier.startpage400
dc.identifier.urihttps://dergipark.org.tr/en/pub/clinexphealthsci/issue/76407/1126447
dc.identifier.urihttps://hdl.handle.net/11424/290968
dc.identifier.volume13
dc.language.isoeng
dc.relation.ispartofCLINICAL AND EXPERIMENTAL HEALTH SCIENCES
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectMedicine
dc.subjectHealth Sciences
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectClinical Medicine (MED)
dc.subjectCLINICAL MEDICINE
dc.subjectColon cancer
dc.subjectgrowth arrest-specific 6
dc.subjectpatient
dc.subjectplasma levels
dc.titleDetermination of the Plasma Levels of Growth Arrest Specific 6 in Colon Cancer Patients
dc.typearticle
dspace.entity.typePublication
local.avesis.idd5f08ed0-b218-4375-a3d3-2631bb126fda
relation.isAuthorOfPublication44b61e5d-4045-4d63-926e-2f01c3ee5642
relation.isAuthorOfPublication.latestForDiscovery44b61e5d-4045-4d63-926e-2f01c3ee5642

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
file.pdf
Size:
353.83 KB
Format:
Adobe Portable Document Format
Download

Collections

Research Outputs